Alpha 2.0
Login Register
» Articles » PMID: 18772463

Hypoparathyroidism: is It Time for Replacement Therapy?

Overview
Journal J Clin Endocrinol Metab
Publisher Oxford University Press
Specialty Endocrinology
Date 2008 Sep 6
PMID 18772463
Citations 11
Authors
Mara J Horwitz
Andrew F Stewart
Affiliations
Soon will be listed here.
Citing Articles

A Higher Concentration of Dialysate Magnesium to Reduce the Frequency of Muscle Cramps: A Narrative Review.

Varghese A, Lacson Jr E, Sontrop J, Acedillo R, Al-Jaishi A, Anderson S Can J Kidney Health Dis. 2020; 7:2054358120964078.

PMID: 33149925 PMC: 7585892. DOI: 10.1177/2054358120964078.

Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).

Chen K, Gosmanova E, Curhan G, Ketteler M, Rubin M, Swallow E J Clin Endocrinol Metab. 2020; 105(10).

PMID: 32738041 PMC: 7470469. DOI: 10.1210/clinem/dgaa490.

Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.

Winer K, Kelly A, Johns A, Zhang B, Dowdy K, Kim L J Pediatr. 2018; 203:391-399.e1.

PMID: 30470382 PMC: 6298875. DOI: 10.1016/j.jpeds.2018.08.010.

Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study.

Upreti V, Somani S, Kotwal N Indian J Endocrinol Metab. 2017; 21(3):415-418.

PMID: 28553597 PMC: 5434725. DOI: 10.4103/ijem.IJEM_340_16.

Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.

Kim E, Keating G Drugs. 2015; 75(11):1293-303.

PMID: 26177893 DOI: 10.1007/s40265-015-0438-2.

References
1.
Neer R, Arnaud C, Zanchetta J, Prince R, Gaich G, Reginster J . Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344(19):1434-41. DOI: 10.1056/NEJM200105103441904. View
2.
Tashjian Jr A, Gagel R . Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res. 2006; 21(3):354-65. DOI: 10.1359/JBMR.051023. View
3.
Lindsay R, Nieves J, HENNEMAN E, Shen V, Cosman F . Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients. J Clin Endocrinol Metab. 1993; 77(6):1535-9. DOI: 10.1210/jcem.77.6.8263137. View
4.
Tashjian Jr A, Goltzman D . On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84). J Bone Miner Res. 2008; 23(6):803-11. DOI: 10.1359/jbmr.080208. View
5.
Stewart A . Translational implications of the parathyroid calcium receptor. N Engl J Med. 2004; 351(4):324-6. DOI: 10.1056/NEJMp048153. View